Group 1 - The company, Shiliu Cloud Medical (POM.US), plans to issue 5 million American Depositary Shares (ADS) at a price range of $4-6 per share, aiming to raise approximately $25 million, with an expected market capitalization of $592 million based on the midpoint of the price range [1] - The IPO process is highlighted as a significant event, with the final pricing and listing date potentially having a direct impact on the stock price [1] Group 2 - In late July 2025, the stock experienced significant volatility, with a sudden surge in trading volume reaching a peak of 12 million shares in a single day, resulting in a turnover rate of 1400%, followed by a rapid pullback [2] - This unusual trading activity reflects the company's small market capitalization of approximately $14 million prior to the IPO, making it susceptible to short-term speculative trading [2] Group 3 - According to the August 2025 prospectus, the company has not yet achieved profitability, reporting a net loss of 37.365 million RMB for 2024, with total liabilities amounting to 546 million RMB and total assets of only 46.2276 million RMB, indicating a solvency issue [3] - The revenue structure shows that over 70% of the income is derived from the pharmaceutical supply chain business, which has a low gross margin, putting pressure on profitability [3]